Scandinavian ChemoTech receives approval from the European Patent Office
Scandinavian ChemoTech AB announces today that the Company has received approval from the European Patent Office. The final injunction for this patent application was announced in a press release on the 3[d ]of February 2021. The examiner announces that the approval will be published 7[th] of July 2021.The patent covers a specially developed electrode as well as unique dynamic properties, which already exist in the TSE platform, intended to treat tumours without damaging important parts of organs and tissues such as nerve pathways and blood vessels. This is of utmost importance in the